This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars
Study sponsor: Latigo Biotherapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-08-08Actual
Enrollment · participants250Actual
Source updated2026-05-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.